Caroline A. Browne - Publications

Affiliations: 
UCC, Portales, NM, United States 

35 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Yost JG, Browne CA, Lucki I. (2R,6R)-hydroxynorketamine (HNK) reverses mechanical hypersensitivity in a model of localized inflammatory pain. Neuropharmacology. 109276. PMID 36198332 DOI: 10.1016/j.neuropharm.2022.109276  0.609
2022 Namchuk AB, Lucki I, Browne CA. Buprenorphine as a Treatment for Major Depression and Opioid Use Disorder. Advances in Drug and Alcohol Research. 2. PMID 36177442 DOI: 10.3389/adar.2022.10254  0.693
2022 Yost JG, Wulf HA, Browne CA, Lucki I. . The Journal of Pharmacology and Experimental Therapeutics. PMID 35779947 DOI: 10.1124/jpet.122.001278  0.672
2022 Browne CA, Clarke G, Fitzgerald P, O'Sullivan J, Dinan TG, Cryan JF. Distinct post-sepsis induced neurochemical alterations in two mouse strains. Brain, Behavior, and Immunity. 104: 39-53. PMID 35569797 DOI: 10.1016/j.bbi.2022.05.005  0.515
2022 Wulf HA, Browne CA, Zarate CA, Lucki I. Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors. Psychopharmacology. PMID 35459958 DOI: 10.1007/s00213-022-06118-4  0.708
2021 Browne CA, Hildegard A Wulf BA, Jacobson ML, Oyola M, Wu TJ, Lucki I. Long-term increase in sensitivity to ketamine's behavioral effects in mice exposed to mild blast induced traumatic brain injury. Experimental Neurology. 113963. PMID 34968423 DOI: 10.1016/j.expneurol.2021.113963  0.637
2021 Kostelnik C, Lucki I, Choi KH, Browne CA. Translational relevance of fear conditioning in rodent models of mild traumatic brain injury. Neuroscience and Biobehavioral Reviews. PMID 33961927 DOI: 10.1016/j.neubiorev.2021.04.037  0.622
2021 Browne CA, Wulf H, Lucki I. Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder. Handbook of Experimental Pharmacology. PMID 33580854 DOI: 10.1007/164_2020_432  0.717
2020 Jacobson ML, Wulf HA, Browne CA, Lucki I. The kappa opioid receptor antagonist aticaprant reverses behavioral effects from unpredictable chronic mild stress in male mice. Psychopharmacology. PMID 32894343 DOI: 10.1007/s00213-020-05649-y  0.728
2020 Jacobson ML, Wulf HA, Tsuda MC, Browne CA, Lucki I. Sex differences in the modulation of mouse nest building behavior by kappa opioid receptor signaling. Neuropharmacology. 108254. PMID 32726598 DOI: 10.1016/j.neuropharm.2020.108254  0.693
2020 Browne CA, Smith T, Lucki I. Behavioral effects of the kappa opioid receptor partial agonist nalmefene in tests relevant to depression. European Journal of Pharmacology. 172948. PMID 31991139 DOI: 10.1016/j.ejphar.2020.172948  0.749
2020 Jacobson ML, Browne CA, Lucki I. Kappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders. Annual Review of Pharmacology and Toxicology. 60: 615-636. PMID 31914893 DOI: 10.1146/annurev-pharmtox-010919-023317  0.715
2020 Browne CA, Jacobson ML, Lucki I. Novel Targets to Treat Depression: Opioid-Based Therapeutics. Harvard Review of Psychiatry. 28: 40-59. PMID 31913981 DOI: 10.1097/HRP.0000000000000242  0.713
2020 Jacobson ML, Simmons SC, Wulf HA, Cheng H, Feng Y, Nugent FS, Browne CA, Lucki I. Protracted Effects of Ketamine Require Immediate Kappa Opioid Receptor Activation and Long‐Lasting Desensitization The Faseb Journal. 34: 1-1. DOI: 10.1096/fasebj.2020.34.s1.04214  0.68
2020 Kaminsky Z, Longley M, Rosoff D, Luo A, Sun H, Hodgkinson C, Goldman D, Schwandt M, Lucki I, Browne C, Lee J, Charlet K, Muench C, Lohoff F. Epigenome-Wide Association Study of Individuals With Alcohol Use Disorder and Suicidal Behavior: Identification and Replication of TIMP2 as Novel Target Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.132  0.629
2019 Browne CA, Lucki I. Targeting opioid dysregulation in depression for the development of novel therapeutics. Pharmacology & Therapeutics. PMID 31051197 DOI: 10.1016/j.pharmthera.2019.04.009  0.697
2018 Browne CA, Hammack R, Lucki I. Dysregulation of the Lateral Habenula in Major Depressive Disorder. Frontiers in Synaptic Neuroscience. 10: 46. PMID 30581384 DOI: 10.3389/fnsyn.2018.00046  0.667
2018 Shepard RD, Langlois LD, Browne CA, Berenji A, Lucki I, Nugent FS. Ketamine Reverses Lateral Habenula Neuronal Dysfunction and Behavioral Immobility in the Forced Swim Test Following Maternal Deprivation in Late Adolescent Rats. Frontiers in Synaptic Neuroscience. 10: 39. PMID 30425634 DOI: 10.3389/Fnsyn.2018.00039  0.668
2018 Jacobson ML, Wulf HA, Browne CA, Lucki I. Opioid modulation of cognitive impairment in depression. Progress in Brain Research. 239: 1-48. PMID 30314565 DOI: 10.1016/bs.pbr.2018.07.007  0.696
2018 Authement ME, Langlois LD, Shepard RD, Browne CA, Lucki I, Kassis H, Nugent FS. A role for corticotropin-releasing factor signaling in the lateral habenula and its modulation by early-life stress. Science Signaling. 11. PMID 29511121 DOI: 10.1126/Scisignal.Aan6480  0.641
2017 Browne CA, Falcon E, Robinson SA, Berton O, Lucki I. Reversal of stress-induced social interaction deficits by buprenorphine. The International Journal of Neuropsychopharmacology. PMID 29020387 DOI: 10.1093/Ijnp/Pyx079  0.713
2017 Browne CA, Erickson RL, Blendy JA, Lucki I. Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism. Neuropharmacology. PMID 28188737 DOI: 10.1016/j.neuropharm.2017.02.005  0.708
2017 Erickson RL, Browne CA, Lucki I. Hair corticosterone measurement in mouse models of type 1 and type 2 diabetes mellitus. Physiology & Behavior. PMID 28089708 DOI: 10.1016/j.physbeh.2017.01.018  0.636
2016 Robinson SA, Erickson RL, Browne CA, Lucki I. A role for the mu opioid receptor in the antidepressant effects of buprenorphine. Behavioural Brain Research. PMID 27818236 DOI: 10.1016/j.bbr.2016.10.050  0.776
2016 Falcon E, Browne CA, Leon RM, Fleites VC, Sweeney R, Kirby LG, Lucki I. Antidepressant-Like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26979295 DOI: 10.1038/Npp.2016.38  0.793
2015 Browne CA, van Nest DS, Lucki I. Antidepressant-like effects of buprenorphine in rats are strain dependent. Behavioural Brain Research. 278: 385-92. PMID 25453747 DOI: 10.1016/j.bbr.2014.10.014  0.687
2014 Browne CA, Hanke J, Rose C, Walsh I, Foley T, Clarke G, Schwegler H, Cryan JF, Yilmazer-Hanke D. Effect of acute swim stress on plasma corticosterone and brain monoamine levels in bidirectionally selected DxH recombinant inbred mouse strains differing in fear recall and extinction. Stress (Amsterdam, Netherlands). 17: 471-83. PMID 25117886 DOI: 10.3109/10253890.2014.954104  0.604
2014 Arnold SE, Lucki I, Brookshire BR, Carlson GC, Browne CA, Kazi H, Bang S, Choi BR, Chen Y, McMullen MF, Kim SF. High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice. Neurobiology of Disease. 67: 79-87. PMID 24686304 DOI: 10.1016/J.Nbd.2014.03.011  0.724
2013 Browne CA, Lucki I. Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants. Frontiers in Pharmacology. 4: 161. PMID 24409146 DOI: 10.3389/fphar.2013.00161  0.71
2013 Browne CA, Clarke G, Hanke J, Dinan TG, Schwegler H, Yilmazer-Hanke DM, Cryan JF. Alterations in prefrontal cortical serotonin and antidepressant-like behavior in a novel C3H/HeJxDBA/2J recombinant inbred mouse strain. Behavioural Brain Research. 236: 283-8. PMID 22960457 DOI: 10.1016/j.bbr.2012.08.012  0.603
2012 Browne CA, O'Brien FE, Connor TJ, Dinan TG, Cryan JF. Differential lipopolysaccharide-induced immune alterations in the hippocampus of two mouse strains: effects of stress. Neuroscience. 225: 237-48. PMID 22917616 DOI: 10.1016/j.neuroscience.2012.08.031  0.59
2012 Browne CA, Clarke G, Dinan TG, Cryan JF. An effective dietary method for chronic tryptophan depletion in two mouse strains illuminates a role for 5-HT in nesting behaviour. Neuropharmacology. 62: 1903-15. PMID 22212181 DOI: 10.1016/j.neuropharm.2011.12.009  0.551
2011 Browne CA, Clarke G, Dinan TG, Cryan JF. Differential stress-induced alterations in tryptophan hydroxylase activity and serotonin turnover in two inbred mouse strains. Neuropharmacology. 60: 683-91. PMID 21130784 DOI: 10.1016/j.neuropharm.2010.11.020  0.584
2009 Browne C, Clarke G, Dinan T, Cryan J. P.2.03 Restraint stress alters tryptophan hydroxylase 2 activity in BALB/c mice: relevance to depression European Neuropsychopharmacology. 19: S35-S36. DOI: 10.1016/S0924-977X(09)70041-0  0.594
2008 Browne C, O'Brien F, Connor T, Cryan J. P.2.10 Aberrant cytokine response to stress in BALB/c mice after lipopolysaccharide (LPS) challenge: relevance of tryptophan hydroxylase 2 European Neuropsychopharmacology. 18: s44-s45. DOI: 10.1016/S0924-977X(08)70051-8  0.548
Show low-probability matches.